insights_auto
Why is MEOBF up 10,07%?
Dive Deeperchevron_right
MEOBF:OTCMKTS
Mesoblast Ltd
US$1,53
arrow_upward
+10,07%(+0,14) 1D
9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEOBF...
Open
US$1,53
High
US$1,53
Low
US$1,53
Mkt. cap
1,82 ຕື້
Avg. vol.
387,00
Volume
100,00
52-wk high
US$2,59
52-wk low
US$1,14
Beta
1,68
Shares outstanding
1,30 ຕື້
No. of employees
108
Open
US$1,53
High
US$1,53
Low
US$1,53
Mkt. cap
1,82 ຕື້
Avg. vol.
387,00
Volume
100,00
52-wk high
US$2,59
52-wk low
US$1,14
Beta
1,68
Shares outstanding
1,30 ຕື້
No. of employees
108
News stories
From web sources and news partners
AD HOC NEWS
·
2 ມື້ກ່ອນ
Mesoblast stock reports fiscal revenue of USD 120.3 million
AD HOC NEWS
·
3 ມື້ກ່ອນ
Mesoblast wins FDA assay approval: what it means for Mesoblast stock
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd